These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36828810)

  • 1. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell-specific molecule 1 drives cervical cancer progression.
    Lu J; Liu Q; Zhu L; Liu Y; Zhu X; Peng S; Chen M; Li P
    Cell Death Dis; 2022 Dec; 13(12):1043. PubMed ID: 36522312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer.
    Jiang JZ; Qiao YB; Zhu XR; Gu QH; Lu JJ; Ye ZY; Xu L; Liu YY
    Cell Death Dis; 2024 Sep; 15(9):699. PubMed ID: 39349432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer.
    Zhu XR; Peng SQ; Wang L; Chen XY; Feng CX; Liu YY; Chen MB
    Cell Death Dis; 2021 Oct; 12(10):918. PubMed ID: 34620839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway.
    Lin M; Xiao Y; Dai Y; Mao Y; Xu L; Zhang Q; Chen Z
    Clin Transl Oncol; 2024 Apr; 26(4):951-965. PubMed ID: 37848695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
    Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
    Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Gαi3 as a promising target for osteosarcoma treatment.
    Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
    Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J; Lv J; Chen J; Zhang X; Ji Y
    Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
    [No Abstract]   [Full Text] [Related]  

  • 14. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway.
    Xu Q; Ma J; Lei J; Duan W; Sheng L; Chen X; Hu A; Wang Z; Wu Z; Wu E; Ma Q; Li X
    Biomed Res Int; 2014; 2014():546353. PubMed ID: 24812621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro.
    Qian X; Bi QY; Wang ZN; Han F; Liu LM; Song LB; Li CY; Zhang AQ; Ji XM
    J Ethnopharmacol; 2023 May; 307():116198. PubMed ID: 36690307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.